Does CERTOLIZUMAB PEGOL Cause Hypertransaminasaemia? 39 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Hypertransaminasaemia have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.0% of all adverse event reports for CERTOLIZUMAB PEGOL.
39
Reports of Hypertransaminasaemia with CERTOLIZUMAB PEGOL
0.0%
of all CERTOLIZUMAB PEGOL reports
12
Deaths
19
Hospitalizations
How Dangerous Is Hypertransaminasaemia From CERTOLIZUMAB PEGOL?
Of the 39 reports, 12 (30.8%) resulted in death, 19 (48.7%) required hospitalization, and 31 (79.5%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Hypertransaminasaemia Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX